Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Healthcare
Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select... see more

TSX:GUD - Post Discussion

Knight Therapeutics Inc > New Investor Presentation
View:
Post by gudisgood on May 29, 2022 6:23am

New Investor Presentation

Here's the link:

https://www.gud-knight.com/wp-content/uploads/GUD-Corp-presentation_05-2022.pdf

Nice to see the Innovative pipeline looking a little stronger now. :)
Comment by MrMugsy on May 29, 2022 2:24pm
Thank You. Love the key achievements on page 26 too - and - geographic partner of choice - with - financial strength. ----------- Had a young Brazilian gentleman stay with us recently for a few weeks ... quizzed him on his health coverage and medications.  It's a great place for Knight ... IMO.
Comment by Chianchin on May 29, 2022 8:22pm
Lula is winning bye ...bye knight
Comment by longrun86 on May 30, 2022 12:46am
I liked it too! They are starting to better articulate the strategy and growth plan. I don't expect Knight to make this information public; however, if anyone comes across information regarding market share in Brazil I would greatly appreciate it :) LR
Comment by gudisgood on Jun 01, 2022 4:12pm
The presentation was updated again: https://www.gud-knight.com/wp-content/uploads/GUD-Corp-presentation_06-2022.pdf
Comment by MrMugsy on Jun 01, 2022 5:21pm
What are those canadian assests on page 10? Did I fall asleep along the way? AKYNZEO - CAN/LATAM ALOXI - CAN Approved, pending transition ????
Comment by MrMugsy on Jun 01, 2022 5:25pm
OK - that's the early May deal with Helsinn. Give me a break - living through long covid hahaha !
Comment by Chianchin on Jun 01, 2022 7:19pm
Are you blind? Did yu not see how the share price reacted to the news you are pumping? 
Knight Therapeutics Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities